COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology
January 04, 2022 07:00 ET
|
COMPASS Pathways
Study demonstrates feasibility of simultaneous administration of COMP360 psilocybin in a controlled setting to healthy participants with 1:1 therapist support London, UK – 4 January...